![PDF) Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study | Valeriu Crudu - Academia.edu PDF) Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study | Valeriu Crudu - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/26691300/mini_magick20190426-2620-1me3opp.png?1556347894)
PDF) Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study | Valeriu Crudu - Academia.edu
![In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis | Scientific Reports In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-21025-6/MediaObjects/41598_2022_21025_Fig1_HTML.png)
In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis | Scientific Reports
![Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology](https://www.futuremedicine.com/cms/10.2217/fmb.11.84/asset/images/medium/figure2.gif)
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology
![Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk | Scientific Reports Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-59164-3/MediaObjects/41598_2020_59164_Fig2_HTML.png)
Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk | Scientific Reports
![A2.5 Information sheet: Practical considerations for implementation of the Cepheid Xpert MTB/XDR test | TB Knowledge Sharing A2.5 Information sheet: Practical considerations for implementation of the Cepheid Xpert MTB/XDR test | TB Knowledge Sharing](https://tbksp.org/sites/default/files/inline-images/Table-A2-5.gif)
A2.5 Information sheet: Practical considerations for implementation of the Cepheid Xpert MTB/XDR test | TB Knowledge Sharing
![Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin - Abstract - Europe PMC Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin - Abstract - Europe PMC](https://europepmc.org/articles/PMC8240501/bin/nCD014841-FIG-01.jpg)
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin - Abstract - Europe PMC
Xpert MTB RIF ENGLISH Package Insert 301 1404 Rev F | PDF | Tuberculosis | Reverse Transcription Polymerase Chain Reaction
![PDF) Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study PDF) Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study](https://i1.rgstatic.net/publication/351418549_Clinical_evaluation_of_the_Xpert_MTBXDR_assay_for_rapid_detection_of_isoniazid_fluoroquinolone_ethionamide_and_second-line_drug_resistance_A_cross-sectional_multicentre_diagnostic_accuracy_study/links/60969500a6fdccaebd179cc3/largepreview.png)
PDF) Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study
![Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second line injectable drug-resistance directly from Mycobacterium tuberculosis positive sputum | bioRxiv Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second line injectable drug-resistance directly from Mycobacterium tuberculosis positive sputum | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/09/09/2020.09.08.288787/F3.large.jpg)
Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second line injectable drug-resistance directly from Mycobacterium tuberculosis positive sputum | bioRxiv
![Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology](https://www.futuremedicine.com/cms/10.2217/fmb.11.84/asset/images/medium/figure3.gif)
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology
![Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay | Journal of Clinical Microbiology Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay | Journal of Clinical Microbiology](https://journals.asm.org/cms/10.1128/jcm.00128-10/asset/1f4e1fa0-8ef6-40bd-9961-cf738bbe8f93/assets/graphic/zjm9990999080003.jpeg)
Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay | Journal of Clinical Microbiology
![New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs - Jul 16, 2020 New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs - Jul 16, 2020](https://mma.prnewswire.com/media/1215469/XDR.jpg)
New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs - Jul 16, 2020
![Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study | medRxiv Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/05/07/2021.05.06.21256505/F3.large.jpg)
Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study | medRxiv
![PDF) Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second-line injectable drug-resistance directly from Mycobacterium tuberculosis positive sputum PDF) Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second-line injectable drug-resistance directly from Mycobacterium tuberculosis positive sputum](https://i1.rgstatic.net/publication/347816219_Xpert_MTBXDR_A_ten-color_reflex_assay_suitable_for_point_of_care_settings_to_detect_isoniazid-_fluoroquinolone-_and_second-line_injectable_drug-resistance_directly_from_Mycobacterium_tuberculosis_posi/links/65697216b1398a779dc88920/largepreview.png)